Method of treating a disease using a glycolytic dependent compound
US11986489B2 · kind B2 · utility
1Cited by
4References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 4, 2021 |
| Grant date | May 21, 2024 |
| Priority date | — |
| Expiry date | Dec 19, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods of enhancing toxicity of a glycolytic dependent compound towards a cancerous tissue and/or organ in a subject, the method being comprised of targeting the glycolytic dependent compound to the cancerous tissue and/or organ by placing oxidized regenerated cellulose (ORC) and/or oxidized cellulose (OC) in direct connection with the cancerous tissue and/or organ, and administering the glycolytic dependent compound to the subject by a systemic route.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.